| [1] |
CHEN Fujun, CHEN Maoming.
Status of clinical research on pancreatic enzyme markers
[J]. Laboratory Medicine, 2025, 40(9): 918-924.
|
| [2] |
GAO Xiantong, YAO Qianqian, RU Lijuan.
Establishment and clinical application evaluation of early warning model for acute pancreatitis complicated with AKI
[J]. Laboratory Medicine, 2025, 40(8): 775-781.
|
| [3] |
LOU Zhan, PENG Tao, LIU Xingliang, YUE Binghong, LI Ran, ZHI Yongyi.
Changes of serum NFL,Cys C and Lp-PLA2 levels in patients with vascular Parkinsonism and their clinical significance
[J]. Laboratory Medicine, 2024, 39(9): 828-833.
|
| [4] |
WANG Hao, XIA Wenying, TONG Wei, WU Wenjia.
Level change and clinical significance of serum lipoprotein-associated phospholipase A2 in patients with depression
[J]. Laboratory Medicine, 2024, 39(9): 871-874.
|
| [5] |
LIU Yadong, YANG Lei, SONG Shaoting, DU Xiong, LIU Qiang, SUN Jianrong.
Correlation between Lp-PLA2 gene polymorphism and histopathological staining of carotid plaque
[J]. Laboratory Medicine, 2024, 39(7): 621-626.
|
| [6] |
WU Shaohua, XI Junnan, LIU Liang, WU Yating, ZHANG Meng, CHEN Liwei, XUE Meng, LIU Shifu.
Prognostic roles of Lp-PLA2,HDAC3 and TAFI levels in patients with large-scale cerebral infarction
[J]. Laboratory Medicine, 2024, 39(11): 1091-1096.
|
| [7] |
TANG Qingqin, QIAO Longwei, YIN Jingping, ZHANG Sheng, FENG Bin, LIANG Yuting.
Correlation of peripheral blood monocyte count and serum anti-phospholipase A2 receptor antibody in patients with nephrotic syndrome
[J]. Laboratory Medicine, 2023, 38(7): 647-652.
|
| [8] |
WANG Haiping, LI He.
BISAP score combined with serum sRAGE for predicting hyperlipidemic acute pancreatitis severity and short-term prognosis
[J]. Laboratory Medicine, 2023, 38(7): 653-658.
|
| [9] |
WANG Yajie, ZU Bailing, GAN Chenxin, WU Jiaoxiang, SHU Jie, HANG Chen, CHEN Minghui, LIN Fujun, HU Zhigang, HUANG Biao, SHENG Huiming.
Identification of plasma differential peptids in PLA2R1-related membranous nephropathy patients
[J]. Laboratory Medicine, 2023, 38(3): 223-229.
|
| [10] |
FAN Lieying.
Research status and application prospects of biomarkers for membranous nephropathy
[J]. Laboratory Medicine, 2023, 38(12): 1111-1114.
|
| [11] |
SUN Lincheng, LI Jianfeng, CHENG Weili, JI Panyun.
Roles of anti-PLA2R IgG4 antibody and PLA2R IgG4/IgG ratio in primary membranous nephropathy
[J]. Laboratory Medicine, 2023, 38(12): 1115-1120.
|
| [12] |
ZHANG Cheng, FEI Chunxia, FU Lin, GAO Chenfei, NI Dongying.
Correlation analysis of FGF-2,Lp-PLA2 and IGF-1 levels and disease severity in patients with diabetic foot
[J]. Laboratory Medicine, 2022, 37(9): 826-830.
|
| [13] |
HU Jinya, MU Bin, MENG Xiang'an.
Relationship between the changes of Aβ1-42,Tau protein,Lp-PLA2 levels and electroencephalogram in patients with mild cognitive impairment
[J]. Laboratory Medicine, 2022, 37(11): 1044-1048.
|
| [14] |
MAN Chunlu, YANG Qingsong.
Clinical value of serum lipoprotein-related phospholipase A2 combined with superoxide dismutase in predicting mild cognitive impairment in cerebral small vessel disease patients
[J]. Laboratory Medicine, 2022, 37(10): 939-943.
|
| [15] |
XIAO Yingyan, CUI Yan, LI Yan.
Research progress of intestinal microbiota and IL-6/gp130 signaling pathway in acute pancreatitis pathogenesis
[J]. Laboratory Medicine, 2021, 36(5): 565-568.
|